Last reviewed · How we verify

Rectalgan Mousse — Competitive Intelligence Brief

Rectalgan Mousse (Rectalgan Mousse) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical rectal analgesic/anti-inflammatory. Area: Gastroenterology.

marketed Topical rectal analgesic/anti-inflammatory Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Rectalgan Mousse (Rectalgan Mousse) — University of Roma La Sapienza. Rectalgan Mousse is a topical rectal formulation that provides local anesthetic and anti-inflammatory effects for symptomatic relief of rectal pain and discomfort.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Rectalgan Mousse TARGET Rectalgan Mousse University of Roma La Sapienza marketed Topical rectal analgesic/anti-inflammatory

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical rectal analgesic/anti-inflammatory class)

  1. University of Roma La Sapienza · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Rectalgan Mousse — Competitive Intelligence Brief. https://druglandscape.com/ci/rectalgan-mousse. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: